RECRUITING

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective is to demonstrate the feasibility of incorporating VR distraction into the brachytherapy and radiotherapy clinical workflow. The secondary objective is to determine if VR distraction during brachytherapy treatment for cervical cancer improves subjects' satisfaction, procedural/acute pain, and need for analgesics or anxiolytics.

Official Title

Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy

Quick Facts

Study Start:2022-08-08
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05440760

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female, ≥ 18 years of age
  2. * Histopathologic diagnosis of gynecologic cancer (endometrial, cervical, vaginal, vulvar) that requires intracavitary brachytherapy with a tandem or interstitial brachytherapy
  3. * Able to provide written consent
  1. * Severe vision or hearing problems that may hinder the ability to see or hear clearly through the VR headset or other condition that may interfere with the placement of the VR headset such as a head, ear or facial wound
  2. * History of seizure disorder, severe motion sickness, dizziness, or migraine headaches precipitated by visual auras
  3. * Known history of elevated intraocular pressure
  4. * Claustrophobia, thalassophobia, cleithrophobia or similar phobias
  5. * Any other significant medical or psychiatric conditions which, in the opinion of the enrolling investigator, may interfere with consent or compliance of the treatment regimen

Contacts and Locations

Study Contact

Joseph A Holley
CONTACT
501-686-8274
jaholley@uams.edu
Matthew R Kovak
CONTACT
501-686-8274
mrkovak@uams.edu

Principal Investigator

Gary Lewis, MD
PRINCIPAL_INVESTIGATOR
University of Arkansas

Study Locations (Sites)

University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
United States

Collaborators and Investigators

Sponsor: University of Arkansas

  • Gary Lewis, MD, PRINCIPAL_INVESTIGATOR, University of Arkansas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-08
Study Completion Date2026-12

Study Record Updates

Study Start Date2022-08-08
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • Brachytherapy
  • Virtual Reality

Additional Relevant MeSH Terms

  • Endocervical Cancer